MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 112 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,389,574 | +289.5% | 328,784 | +218.9% | 0.03% | +300.0% |
| Q2 2023 | $2,667,456 | +165.9% | 103,110 | +115.9% | 0.01% | +133.3% |
| Q3 2022 | $1,003,000 | -57.5% | 47,748 | -60.6% | 0.00% | -62.5% |
| Q2 2022 | $2,360,000 | -45.3% | 121,292 | -38.1% | 0.01% | -38.5% |
| Q1 2022 | $4,313,000 | +59.1% | 195,879 | +15.2% | 0.01% | +116.7% |
| Q4 2021 | $2,711,000 | -12.4% | 169,977 | +9.5% | 0.01% | -14.3% |
| Q3 2021 | $3,093,000 | +90.5% | 155,275 | +65.3% | 0.01% | +75.0% |
| Q2 2021 | $1,624,000 | -14.7% | 93,915 | -2.2% | 0.00% | -20.0% |
| Q1 2021 | $1,903,000 | +626.3% | 96,020 | +540.1% | 0.01% | +400.0% |
| Q4 2020 | $262,000 | -74.2% | 15,000 | -71.6% | 0.00% | -75.0% |
| Q3 2020 | $1,017,000 | +16.6% | 52,783 | +17.8% | 0.00% | 0.0% |
| Q2 2020 | $872,000 | – | 44,793 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |